Your browser doesn't support javascript.
loading
Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells.
Shui, Yifang; Hu, Xin; Hirano, Hiroshi; Tsukamoto, Hirotake; Guo, Wen-Zhi; Hasumi, Kenichiro; Ijima, Fumihiro; Fujino, Masayuki; Li, Xiao-Kang.
Afiliación
  • Shui Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Hu X; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Hirano H; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Tsukamoto H; Department of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Japan.
  • Guo WZ; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: fccguowz@zzu.edu.cn.
  • Hasumi K; Hasumi International Research Foundation, Tokyo, Japan.
  • Ijima F; Hasumi International Research Foundation, Tokyo, Japan. Electronic address: ijima@shukokai.org.
  • Fujino M; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Management Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: mfujino-kkr@umin.ac.jp.
  • Li XK; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address: ri-k@ncchd.go.jp.
Neoplasia ; 39: 100893, 2023 05.
Article en En | MEDLINE | ID: mdl-36893559
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón